The Italian Medicines Agency has launched the English version of the institutional portal www.aifa.gov.it  accessible by selecting the "ENG" item at the top right of the website homepage.

Through the “English version” of the portal, the Agency provides an additional tool to all users, especially to those who are interested in AIFA's services and activities, but have difficulty with the Italian language and who, from Italy or abroad, may wish to consult AIFA’s updates and publications in the most widespread language in the world.

This way AIFA takes a further step forward in a process undertaken for some time now, aiming to provide thorough information as well as timely and transparent answers to the information needs of an increasingly broader audience of users.

“As for the Italian version of the website, the goal is to provide streamlined browsing and a citizen-oriented website, even for foreign users”, AIFA’s DG Nicola Magrini states.

“In this historical moment, marked by the COVID-19 pandemic and its global dimensions”, AIFA’s DG Magrini continues, “the Agency wanted to equip itself to meet the new needs of the population and of all stakeholders. For example, the “COVID-19 emergency” section is already available in English, with all the most relevant and updated information on ongoing trials, on medicines used outside clinical trials, on observational studies related to COVID-19, as well as on correct use of medicines in the population exposed to the virus”.

The contents also include the English versions of the “National Report on Medicines use in Italy - Year 2019” and of the “Report on Medicines use during the COVID-19 epidemic - Year 2020”, which provide a comprehensive description of pharmaceutical care in Italy and of the types of medicines used to treat COVID-19, both at hospital and at a local level.